Company / Share Buybacks
Biogen Share Buybacks History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
-
FY2024
5-year range
$0 / $1.8B
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#42 of 48
Health Care
What the data says
Declined from $750M to $0 over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 48
▼
Key checks
Key Insights
- Peak share buybacks was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $750.0M | -58.3% |
| FY2021 | $1.8B | -73.1% |
| FY2020 | $6.7B | +13.8% |
| FY2019 | $5.9B | +34.8% |
| FY2018 | $4.4B | +218.8% |
| FY2017 | $1.4B | +36.5% |
| FY2016 | $1.0B | -80.0% |
As of FY2024 · SEC 10-K · Updated Mar 3, 2026